GMP Compliance Archives - AES | Automated Engineering Services, Inc.

3 Critical Decisions for Integrating Single-Use Skids with DeltaV

Livia Hallen — Mon, 29 Jun 2026 10:10:08 +0000

DeltaV Modular Facility Automation: An Engineer's Guide to Portability, Repeatability, and Scale

Modular cleanrooms and prefabricated facilities promise faster deployment and easier replication across sites. But the automation strategy behind them often is what decides whether a modular project actually scales— or stalls in validation. We sat down with Tim Schultz, an AES automation engineer currently embedded in an active modular cleanroom build, for practical, DeltaV-specific guidance on what works in the field.

Single-use skids can accelerate biomanufacturing by enabling faster changeovers and flexible capacity. But in a DeltaV-based GMP facility, skid integration is rarely plug-and-play. The biggest risks tend to show up late, during FAT/SAT or commissioning, when teams discover unclear control boundaries, inconsistent alarms, or incomplete vendor handoff documentation.

What Does a Modular Facility Actually Look Like in the Field?

When engineers talk about modular facilities in biotech, what configurations are you most commonly seeing?

One of the ways they leverage DeltaV is by housing I/O cabinets outside the clean rooms and connecting through ceiling connections, so they can alter equipment configurations directly at the I/O level without entering the cleanroom. Across the industry, multi-site replication is also a major driver — companies want facilities that can be duplicated, even down to construction.

“Right now, I’m working with a CMO—a contract manufacturer that produces for multiple clients, so flexibility is a non-negotiable. Their facility is essentially a warehouse with 18 to 20 pre-built, prefab cleanrooms connected by a clean corridor. Some rooms are viral, some aren’t—which changes airflow requirement.”

Tim Schultz

Automation Engineer

Where Does Automation Break in Modular Projects?

What are the most common failure modes you've seen?

“Inconsistent standards. Teams try to build adaptive systems across multiple modules, but the underlying standards aren’t consistent across units—and that breaks replication. It ties directly into validation: if you can use a validated piece, it makes a huge difference. If something is new or altered, it now needs to be validated, and that adds a large layer to the process. So often we end up with a workaround—maybe this isn’t the ideal component, but it’s validated, and it fits. That compromise happens often in this industry. “

The failure modes to watch:

inconsistent standards across units
Modified components mid-project
Vendor black boxes without proper tagging documentation
Skid integration gaps when tag mapping is left too late

What Makes DeltaV the Right Fit for Modular Environments?

Which DeltaV capabilities matter most for portability and scale?

Libraries. That’s the key capability. Any time you have a validated piece of software that can be replicated across units or sites, you’re saving significant time and money.

DeltaV’s library structure is class-based—at the lowest level, you have function blocks, which are validated and documented by Emerson and rarely change. From there, the structure layers— composites, control modules, equipment modules, and unit classes— with validated objects available at every level. DeltaV’s architecture allows you to create instances of those validated objects across different systems. That’s the core of what makes it well-suited for modular portability and scale.

What Should Be Standardized — and What Can Stay Flexible?

Across modular sites and units, what do you lock down versus leave flexible?

Tagging conventions—lock those down. A consistent tagging standard is critical for replication. When you drop in a new unit, only one or two elements of the tag should change. At the site level, that same logic lets you create a new site by simply changing numbers. Faceplates and security roles should also be locked down, especially for DeltaV upgrade compatibility.

What can stay flexible: phase logic and unit logic, particularly with aliasing, and recipes—it’s very easy to add extra parameters and leave them unpopulated. Recipes are highly flexible without requiring structural changes.

Is "Plug-and-Play" Skid Integration Realistic in GMP?

How close can teams get to plug-and-play with skids in a validated environment?

It’s highly unrealistic—particularly for GMP systems that require validation. In a non-GMP, standalone system, you can get relatively close. But in validated biopharma environments, it doesn’t really happen.

The minimum you need from a skid vendor is their P&IDs and tagging structure. Once you pull that into DeltaV or a SCADA system, you can map their tags to your internal structure and enforce consistency from there. Endor tagging conventions vary widely. The job is understanding their structure and building a clean mapping to yours—that discipline is what makes integration manageable.

What specific practices actually cut schedule in modular projects?

How close can teams get to plug-and-play with skids in a validated environment?

Three things. First, leverage validated modules—if the object is already validated, using it again costs almost nothing in validation time. Second, move away from paper-based validation; paper-based validation adds significant time at every step, and the industry has been shifting toward electronic validation for good reason. Third, build a smart validation plan—it’s easy to say “test everything,” but that approach can multiply your schedule by a factor of ten. Knowing what not to test, based on risk and prior validation status, is where experienced teams save weeks.

A robust MES and solid data capture to support the Performance Qualification process also make a real difference in shortening the path to production.

Build for Replication From Day One

Modular facilities don’t fail because the technology isn’t capable—they fail because the automation strategy wasn’t designed for replication from the start.

The principles that hold across every modular project: standardize tagging conventions before configuration begins, leverage validated DeltaV library objects at every level, plan for 21 CFR Part 11 compliance early, and build a risk-based validation plan that defines what not to test. Get those right, and modular automation becomes a competitive advantage rather than a recurring risk.

PARTNER WITH AES

AES supports biotech and biopharma clients at every stage of facility design, automation strategy, and commissioning—including DeltaV modular facility automation for CMOs, CDMOs, and multi-site manufacturers. If your team is designing a modular facility or planning a DeltaV deployment, we'd like to talk.

The post 3 Critical Decisions for Integrating Single-Use Skids with DeltaV appeared first on AES | Automated Engineering Services, Inc..

3 Critical Decisions for Integrating Single-Use Skids with DeltaV

Livia Hallen — Thu, 04 Jun 2026 10:02:15 +0000

3 Critical Decisions for Integrating Single-Use Skids with DeltaV

This article focuses on the decisions that reduce integration risk early. Rather than covering every execution detail, it provides a practical framework for aligning scope, architecture, and responsibility boundaries so projects stay operable, compliant, and on schedule.

Why single-use skid integration creates outsized risk in DeltaV environments

Multi-vendor skids often arrive with different standards for tags, alarms, and data context.
Skids can function as “black boxes,” making ownership boundaries unclear between the skid PLC and site DeltaV.
Late alignment typically drives rework, schedule slips, and avoidable operational risk.

“The failure modes to watch: inconsistent standards across units, introducing modified components mid-project, vendor black boxes without proper tagging documentation, and skid integration gaps when tag mapping is left too late.”

Tim Schultz

Automation Engineer

Let’s design skid integration that works with your DeltaV strategy—not against it.

Our automation engineers bring deep experience in GMP environments, helping standardize tagging, define clear control boundaries, and build scalable architectures that support repeatability from first deployment through multi-site expansion.

The 3 decisions that determine integration success

1: Define control boundaries (who’s in charge of what)

Monitoring only vs supervisory control vs recipe coordination.
Rule of thumb: keep integration simple unless multi-unit coordination or site standards require deeper control.

2: Standardize what operators will see (alarms + data that actually matter)

Align on an “operability baseline” so operators don’t relearn every skid.
Decide which signals must be brought into DeltaV versus left local to the skid.

3: Lock the vendor handoff package early (to avoid FAT/SAT surprises)

Define interface requirements and documentation expectations upfront.
Confirm responsibility split: vendor vs site vs integrator.

“The minimum you need from a skid vendor is their P&IDs and tagging structure… The job is knowing what their tags are and building a clean mapping to yours — that discipline is what makes integration manageable.”

Tim Schultz

Automation Engineer

Single-use skids move fast, but integration risk can quietly erode the schedule if key decisions are delayed. Clear control boundaries, an operability-first approach, and an early vendor handoff agreement are the fastest path to smooth commissioning in DeltaV-based GMP environments.

Need an automation partner who understands DeltaV—and the realities of skid integration?

Request a consultation to learn how AES helps teams integrate single-use skids with the standards, documentation, and architectural discipline required to reduce commissioning risk and accelerate time to operation—without late-stage surprises.

The post 3 Critical Decisions for Integrating Single-Use Skids with DeltaV appeared first on AES | Automated Engineering Services, Inc..

5 Ways the Right Biotech OEM Partner Can Make or Break Your Success

Livia Hallen — Fri, 24 Oct 2025 14:43:49 +0000

5 Ways the Right Biotech OEM Partner Can Make or Break Your Success

Learn the five key factors biotech companies should evaluate when choosing an OEM partner: technical knowledge, customization, compliance, scalability, and support.

Why technical depth, flexibility, compliance, and ongoing support are non-negotiable for successful partnerships

Choosing the right OEM partner is one of the most high-stakes decisions biopharma companies face. From the earliest prototypes to production, seamless development depends on more than a supplier’s catalog—it hinges on their process knowledge, engineering flexibility, and a long-term vision aligned with yours.

Todd Upton, Director of OEM and Service at AES, shares key lessons from his work with companies across the biotech landscape. Drawing on his team’s experience building custom systems for everything from stem cell culture to engineered proteins, Todd helps illuminate what separates a capable vendor from a true partner. This article explores the five essential criteria that biotech companies should consider when selecting an OEM partner.

1. Deep biotech process expertise

Biotech manufacturing isn’t plug-and-play. Systems need to reflect the unique physical, regulatory, and operational demands of each process. “Deep technical knowledge allows the OEM partner to understand the critical nuances needed to design equipment for complex processes,” Todd explains. “This is especially true in areas like stem cell culture or engineered proteins.”

These processes require highly sensitive control systems, precise environmental parameters, and compatibility with rapidly evolving materials and technologies. Without biotech-specific expertise, an OEM risks delivering solutions that introduce friction, fail audits, or require extensive redesigns to work effectively.

Clients often turn to AES with questions about cGMP requirements, 21 CFR Part 11 compliance, and integrating components like Watson Marlow pumps or Raman spectrometers. Questions our team answers with real-world context drawn from previous builds.”. Todd’s team not only answers these questions but contextualizes them with examples from past builds, offering real-world validation without compromising client confidentiality. This level of detail and transparency builds trust and reveals technical depth.

2. Custom-engineered solutions

Every biotech process has its own parameters, and off-the-shelf equipment rarely fits all the pieces together. “The risk of a one-size-fits-all approach is that it doesn’t optimally meet the client’s process requirements,” says Todd. “You might end up with the wrong flow rates or control limitations because the equipment wasn’t purpose-built.”

Customization isn’t a luxury—it’s essential to performance. Todd explains that process-specific needs often involve advanced operations, such as perfusion, capacitance, or spectroscopy-based control. AES’s engineering approach is grounded in adaptability. Whether it’s modifying a bio controller for higher oxygenation levels in stem cell culture or integrating proprietary client technology, AES builds with the process in mind.

“We had to create a highly specific biocontroller to match one client’s unique stem cell platform—that kind of customization made the difference in their ability to scale successfully.”

Todd Upton

Director of OEM & Service

These custom builds are a core part of AES’s offering. Rather than forcing clients to compromise their process for the sake of the equipment, AES engineers solutions that enhance process fidelity and future scalability.

3. Built-in scalability to GMP

One of the biggest risks in equipment design is underestimating the effort required to scale. Many biotech firms approach AES with a functioning R&D setup but no roadmap for GMP production. “The requirements for research labs versus regulated production environments are vastly different,” Todd says. “Traceability, automation layers, cleaning protocols—all of these impact the equipment design.”

“Traceability, automation layers, cleaning protocols—all of these impact the equipment design.”

Todd Upton

Director of OEM & Service

AES bridges the R&D-to-GMP gap from day one. Without accounting for these differences early on, companies often face costly re-engineering or tech transfer delays. AES avoids this by bringing GMP thinking into every phase, even when working on early-stage concepts. They anticipate what regulatory scale-up will require and design accordingly, reducing future risk.

Todd recalls multiple cases where this foresight prevented months of delays and rework. By involving AES early, clients not only receive R&D tools, but they also gain a long-term equipment strategy.

4. Regulatory documentation support

Regulatory approval is a critical milestone, and documentation can be the difference between fast-tracking and failing to meet deadlines. That’s why companies must ensure their OEM partner operates with certified quality systems and structured engineering processes.

Todd explains, “We follow a GMP-compliant systems engineering process that produces the right documentation at every step—from design drawings and URS to IQ/OQ protocols.” AES also holds relevant ISO certifications that clients and regulators expect from top-tier OEM vendors.

This comprehensive documentation not only supports compliance audits but also facilitates smoother tech transfer between geographies, contract development and manufacturing organizations (CDMOs), or departments. Clients benefit from less backtracking, fewer surprises, and faster regulatory progress.

5. Reliable aftermarket services

The sale doesn’t end at delivery, and neither should the relationship. Yet many OEMs treat post-sale support as an afterthought. According to Todd, this is a mistake that can carry serious consequences. “Clients often underestimate the complexity of their systems and the importance of ensuring optimal operation over time,” he notes. “Without proper support, you’re looking at reduced efficiency or obsolete equipment.”

Lack of support can mean unexpected downtime, lost yield, and unexpected costs. AES prioritizes availability, firmware and software updates, and fast issue resolution. Their commitment doesn’t wane once the equipment is installed. Todd emphasizes that their support team’s technical depth and quick turnaround are what long-term clients appreciate most.

“They value our detailed record keeping, fast response times, and internal expertise. We’re not just fixing problems—we’re invested in their success,” he says.

Equipment checklist

Why These Considerations Matter

Choosing an OEM partner in biotech is not just a procurement decision—it’s a strategic investment in your ability to scale, comply, and innovate. From understanding process complexity to offering lifecycle support, the right partner can reduce delays, eliminate rework, and improve operational outcomes.

Companies that prioritize these five factors—technical expertise, customization, scalability, compliance, and aftermarket services—position themselves for smoother growth and fewer setbacks.

AES doesn’t just manufacture equipment. It brings clarity, structure, and shared commitment to every project.

Let’s design equipment that works for your process, not the other way around.

Our OEM experts build GMP-compliant solutions with technical depth, scalability, and lifecycle support—customized to your biotech process from R&D to regulated production.

Need an OEM Partner That Understands Biotech—and Delivers From Day One?

Request a consultation to learn how AES engineers biotech equipment with the compliance, customization, and support needed to scale—without onboarding delays or risk to your process.

The post 5 Ways the Right Biotech OEM Partner Can Make or Break Your Success appeared first on AES | Automated Engineering Services, Inc..

GMP Compliance Archives - AES | Automated Engineering Services, Inc.

3 Critical Decisions for Integrating Single-Use Skids with DeltaV

DeltaV Modular Facility Automation: An Engineer's Guide to Portability, Repeatability, and Scale

Table of Contents

What Does a Modular Facility Actually Look Like in the Field?

When engineers talk about modular facilities in biotech, what configurations are you most commonly seeing?

Where Does Automation Break in Modular Projects?

What are the most common failure modes you've seen?

What Makes DeltaV the Right Fit for Modular Environments?

Which DeltaV capabilities matter most for portability and scale?

What Should Be Standardized — and What Can Stay Flexible?

Across modular sites and units, what do you lock down versus leave flexible?

Is "Plug-and-Play" Skid Integration Realistic in GMP?

How close can teams get to plug-and-play with skids in a validated environment?

What specific practices actually cut schedule in modular projects?

How close can teams get to plug-and-play with skids in a validated environment?

Build for Replication From Day One

Modular facilities don’t fail because the technology isn’t capable—they fail because the automation strategy wasn’t designed for replication from the start.

PARTNER WITH AES

3 Critical Decisions for Integrating Single-Use Skids with DeltaV

3 Critical Decisions for Integrating Single-Use Skids with DeltaV

Table of Contents

Why single-use skid integration creates outsized risk in DeltaV environments

Let’s design skid integration that works with your DeltaV strategy—not against it.

The 3 decisions that determine integration success

1: Define control boundaries (who’s in charge of what)

2: Standardize what operators will see (alarms + data that actually matter)

3: Lock the vendor handoff package early (to avoid FAT/SAT surprises)

Need an automation partner who understands DeltaV—and the realities of skid integration?

Request a consultation to learn how AES helps teams integrate single-use skids with the standards, documentation, and architectural discipline required to reduce commissioning risk and accelerate time to operation—without late-stage surprises.

5 Ways the Right Biotech OEM Partner Can Make or Break Your Success

5 Ways the Right Biotech OEM Partner Can Make or Break Your Success

Table of Contents

Why technical depth, flexibility, compliance, and ongoing support are non-negotiable for successful partnerships

1. Deep biotech process expertise

2. Custom-engineered solutions

3. Built-in scalability to GMP

4. Regulatory documentation support

5. Reliable aftermarket services

Equipment checklist

Why These Considerations Matter

Let’s design equipment that works for your process, not the other way around.

Need an OEM Partner That Understands Biotech—and Delivers From Day One?

Request a consultation to learn how AES engineers biotech equipment with the compliance, customization, and support needed to scale—without onboarding delays or risk to your process.